Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II infant study of Novartis meningococcal ACWY conjugate vaccine with 2-dose or 3-dose schedules
2004-000195-13Phase 2Completed
- Sponsor
- Novartis
- Start
- Feb 2005
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Meningococcal ACWY conjugate vaccine in meningococcal disease (3 arms), sponsored by Novartis. Primary endpoint: Primary immunogenicity endpoint. Started Feb 2005; status: completed.
02
Drugs
Meningococcal ACWY conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on 2004-000195-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000195-13.